A randomized, phase 3, open-label study of nivolumab versus temozolomide (TMZ) in combination with radiotherapy (RT) in adult patients (pts) with newly diagnosed, O-6-methylguanine DNA methyltransferase (MGMT)-unmethylated glioblastoma (GBM): CheckMate-498 Meeting Abstract
| Authors: | Sampson, J. H.; Omuro, A. M. P.; Preusser, M.; Lim, M.; Butowski, N. A.; Cloughesy, T. F.; Strauss, L. C.; Latek, R. R.; Paliwal, P.; Weller, M.; Reardon, D. A. |
| Abstract Title: | A randomized, phase 3, open-label study of nivolumab versus temozolomide (TMZ) in combination with radiotherapy (RT) in adult patients (pts) with newly diagnosed, O-6-methylguanine DNA methyltransferase (MGMT)-unmethylated glioblastoma (GBM): CheckMate-498 |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 112s |
| Language: | English |
| ACCESSION: | WOS:000404665403066 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.TPS2079 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS2079 -- Source: Wos |
